Search results for "Highlights"


 
Results 21 - 30 of about 124 for "Highlights".

Highlights

A multitarget fecal immunochemical test (FIT) could reduce colorectal cancer incidence and death and might be cost-effective, according to a recent validation study.
July 2021

Highlights

A new clinical practice guideline from the American Gastroenterological Association offered recommendations on which drug classes to use for induction and maintenance of remission, as well as some combination therapies.
June 2021

Highlights

Among other guidance, the American College of Gastroenterology recommends anticoagulation for all patients without cirrhosis who have acute symptomatic portal vein thrombosis or mesenteric vein thrombosis in the absence of any contraindication.
January 2020

Highlights

A Taiwanese nationwide cohort study of more than 10,000 patients with chronic hepatitis B showed a statistically significant 29% risk reduction for hepatocellular carcinoma in patients who received daily aspirin compared with matched controls.
March 2019

Highlights

There is no evidence that screening for pancreatic cancer or treating screen-detected disease improves disease-specific morbidity or all-cause mortality in average-risk adults with no symptoms, the U.S. Preventive Services Task Force (USPSTF)
August 2019

Highlights

Significant bleeding occurred in 2.5% of the patients on warfarin and 0.6% of the patients on non-vitamin K antagonist oral anticoagulants (NOACs).
March 2017

Highlights

Lynch syndrome is rare after age 80 years, making the efficiency of universal screening very low, so stopping reflex screening in this age group may be reasonable, particularly in resource-limited settings, the study authors said.
June 2019

Highlights

However, patients who were obese but did not have fatty liver disease were not at increased risk of hospitalization for COVID-19, according to a study of healthy people in a U.K. database who underwent MRI assessment of liver fat markers.
April 2021

Highlights

For postexposure prophylaxis, the hepatitis A vaccine is now preferred to immune globulin for all adults, including those older than 40 years of age, the Advisory Committee on Immunization Practices (ACIP) said.
November 2018

Highlights

No significant between-group differences were seen for low-volume versus high-volume split-dose regimens in adequacy of bowel cleansing, while low-volume regimens had higher odds of patient adherence or completion, tolerability, and willingness to
November 2019

Result Page: Prev   1   2   3   4   5   6   7   8   9   10   Next